These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 1306980)
1. Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis. Hirano T; Manabe T Nihon Geka Hokan; 1992 Nov; 61(6):423-32. PubMed ID: 1306980 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of a cephalosporin, Shiomarin, plus a new potent protease inhibitor, E3123, on rat taurocholate-induced pancreatitis. Hirano T; Manabe T; Imanishi K; Tobe T J Gastroenterol Hepatol; 1993; 8(1):52-9. PubMed ID: 8439663 [TBL] [Abstract][Full Text] [Related]
3. Improved survival in mice with diet-induced pancreatitis treated with new potent protease inhibitor, E-3123 and a broad spectrum antibiotic, cefmetazole. Hirano T; Manabe T; Ohshio G; Nio Y Nihon Geka Hokan; 1992 May; 61(3):213-23. PubMed ID: 1444701 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of combined therapy with a protease inhibitor, ONO 3307, and a xanthine oxidase inhibitor, allopurinol on temporary ischaemic model of pancreatitis in rats. Hirano T; Manabe T; Ohshio G; Nio Y Nihon Geka Hokan; 1992 May; 61(3):224-33. PubMed ID: 1444702 [TBL] [Abstract][Full Text] [Related]
5. Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats: protective effect of a potent new protease inhibitor, E-3123. Hirano T; Manabe T; Yotsumoto F; Ohshio G; Nio Y Nihon Geka Hokan; 1992 May; 61(3):234-48. PubMed ID: 1280076 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis. Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502 [TBL] [Abstract][Full Text] [Related]
7. Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats. Hirano T; Manabe T; Steer M; Printz H; Calne R; Tobe T Surg Gynecol Obstet; 1993 Apr; 176(4):371-81. PubMed ID: 8460415 [TBL] [Abstract][Full Text] [Related]
8. Intracellular action of an exogenous low-molecular-weight synthetic protease inhibitor, E3123, in cerulein-induced acute pancreatitis in rats. Sata N; Atomi Y; Kimura W; Kuroda A; Muto T; Mineo C Int J Pancreatol; 1994 Apr; 15(2):119-27. PubMed ID: 8071570 [TBL] [Abstract][Full Text] [Related]
9. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis. Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013 [TBL] [Abstract][Full Text] [Related]
10. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate]. Hirano T; Manabe T; Tobe T Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776 [TBL] [Abstract][Full Text] [Related]
11. "Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis. Hirano T; Manabe T Nihon Geka Hokan; 1992 Nov; 61(6):433-44. PubMed ID: 1306981 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis. Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204 [TBL] [Abstract][Full Text] [Related]
13. Effect of short-term pancreatico-biliary duct obstruction with intraductal hypertension on subcellular organelle fragility and pancreatic adenylate energy metabolism in rats: protective effect of a new protease inhibitor, E-3123. Hirano T; Manabe T Acta Chir Belg; 1994; 94(2):80-5. PubMed ID: 7517090 [TBL] [Abstract][Full Text] [Related]
14. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis. Hirano T; Manabe T; Tobe T Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294 [TBL] [Abstract][Full Text] [Related]
15. Monitoring serum tryptic activity and effect of trypsin inhibitor on rat acute pancreatitis. Sobajima H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Ishiguro H; Tanikawa M; Nakae Y Digestion; 1994; 55(2):90-6. PubMed ID: 7514553 [TBL] [Abstract][Full Text] [Related]
16. The effect of a cholecystokinin receptor antagonist lorglumid on the proteinase-antiproteinase balance in taurocholate acute experimental pancreatitis (AEP) in rats. Kosidło S; Rydzewska G; Gabryelewicz A Mater Med Pol; 1992; 24(4):223-6. PubMed ID: 1308047 [TBL] [Abstract][Full Text] [Related]
17. Acute cytotoxic effect of cyclosporin A on pancreatic acinar cells in rats. Protective effect of the synthetic protease inhibitor E3123. Hirano T; Manabe T; Ando K; Tobe T Scand J Gastroenterol; 1992; 27(2):103-7. PubMed ID: 1373246 [TBL] [Abstract][Full Text] [Related]
18. Effects of delayed administration of octreotide in acute experimental pancreatitis. Kaplan O; Kaplan D; Casif E; Siegal A; Paran H; Graf E; Skornick Y J Surg Res; 1996 Apr; 62(1):109-17. PubMed ID: 8606496 [TBL] [Abstract][Full Text] [Related]
19. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate. Kimura K; Tominaga K; Fujii M; Saito T; Kasai H Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035 [TBL] [Abstract][Full Text] [Related]